By Kristi Rosa
Data from a retrospective study suggests an adjuvant gastrointestinal (GI)-based chemotherapy regimen is more beneficial than one that is gynecologic-based in patients with mucinous ovarian cancer, said Katherine C. Kurnit, MD.
“Right now, mucinous ovarian cancer is … Read more
This beautifully written piece sheds light on the struggles that caregivers on the cancer journey face after losing their loved one. Caregivers are critical sources of support throughout someone’s cancer journey, but their true strength shines through with how they … Read more
By Anubhuti Matta
Nine months — that’s how long Shradha Gupta, 51, waited for an ovarian cancer diagnosis.
“I had a terrible pain in the pelvic region, felt bloated all the time, but the gynecologist kept asking me to wait … Read more
By Barbara Tako
Cancerland is a frightening place to be for days, weeks, months and yes, even years. Turn that worry into something positive; reach out and be kind today and every day forward.
Before cancer survivorship, I know I … Read more
“There’s that element of anxiety and stress and not necessarily having an educational resource to turn to.”
Over The Counter
23andMe is already allowed to screen customers for mutations associated with an increased risk of breast cancer. … Read more
By Kelly Irvin
Rather than revisiting the ghosts of cancer treatments past, I’m focused on using what I’ve learned in three years of active treatment and maintenance for incurable, metastatic cancer.
My three-year cancerversary is quickly approaching. On Jan. 13, … Read more
Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer Center of the University of Pennsylvania say they’ve identified how to fuel macrophages with … Read more
By Jessica Skarzynski
For some time now, paclitaxel has been considered standard of care in the treatment of patients with platinum-resistant ovarian cancer; however, recent research has shown the addition of the investigational drug alisertib to a paclitaxel regimen demonstrated … Read more
Researchers at The Institute of Cancer Research, London (ICR) have developed an artificial intelligence (AI) test that analyses the shape of tumour cells to identify patients with aggressive ovarian cancer.
The test is intended to enable tailored treatment based on … Read more
Meet Ally, Clearity’s youngest supporter!
Hi, my name is Ally W.! I am 12 years old and I live in California. I’m in 7th grade and I am on the cheerleading team for my middle school. I enjoy baking, cheer, … Read more
Often I have lain under a sheet on a gurney in a hospital
The JAVELIN Ovarian 100 study has been terminated based on the finding, reported as part… Read more
